|
End-of-day quote
Amman S.E.
27/09/2026
|
5-day change | 1st Jan Change | ||
| 3.150 JOD | 0.00% |
|
0.00% | -4.55% |
| 07-29 | Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-03 | Hayat Pharmaceutical Industries Q1 profit 152,598 dinars | RE |
| Market Cap | 29.92M 42.27M 37.19M 35.16M 31.9M 59.96M 4.06B 60.24M 421M 163M 2.07B 159M 155M 6.66B | P/E 2024 |
7.53x | P/E 2025 | 13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 23.84M 33.68M 29.63M 28.01M 25.41M 47.78M 3.23B 48M 336M 129M 1.65B 126M 124M 5.3B | EV / Sales 2024 |
1.08x | EV / Sales 2025 | 1.48x |
| Free-Float |
14.53% | Yield 2024 |
8.98% | Yield 2025 | 5.76% |
| Current month | -1.25% | ||
| 1 month | -1.56% | ||
| 3 months | +0.64% | ||
| 6 months | -0.94% | ||
| Current year | -4.55% |
| 1 week | 3.15 | 3.19 | |
| 1 month | 3.11 | 3.19 | |
| Current year | 3.1 | 3.55 | |
| 1 year | 2.95 | 3.55 | |
| 3 years | 2.4 | 3.55 | |
| 5 years | 2.4 | 4 | |
| 10 years | 1.72 | 4.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 68 | 08/02/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 17/02/2002 | |
Raghda Katkhuda
BRD | Director/Board Member | 71 | 27/11/2009 |
| Director/Board Member | 78 | 08/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +6.06% | +26.00% | 42.24M | ||
| +0.11% | +2.76% | +63.52% | +115.51% | 1,055B | ||
| +0.27% | +0.73% | +51.33% | +73.10% | 654B | ||
| +0.73% | +0.88% | +20.70% | +73.89% | 467B | ||
| -1.36% | -0.39% | +40.20% | +41.03% | 348B | ||
| +1.34% | +5.47% | +23.37% | +31.30% | 275B | ||
| -0.48% | -0.06% | +13.56% | +12.36% | 258B | ||
| +0.85% | +8.42% | +53.17% | +55.45% | 224B | ||
| +0.85% | +1.40% | +35.78% | +101.47% | 187B | ||
| -0.30% | -10.41% | -27.62% | -61.04% | 171B | ||
| Average | +0.07% | +0.67% | +28.01% | +46.91% | 363.84B | |
| Weighted average by Cap. | -0.11% | +1.32% | +40.69% | +69.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.71M 23.6M 20.77M 19.63M 17.81M 33.48M 2.26B 33.63M 235M 90.74M 1.16B 88.59M 86.67M 3.72B | 17.11M 24.16M 21.26M 20.1M 18.24M 34.28M 2.32B 34.44M 241M 92.91M 1.18B 90.71M 88.75M 3.81B |
| Net income | 3.09M 4.36M 3.84M 3.63M 3.29M 6.19M 419M 6.22M 43.47M 16.78M 214M 16.38M 16.03M 687M | 2.31M 3.26M 2.87M 2.71M 2.46M 4.62M 313M 4.65M 32.48M 12.53M 160M 12.24M 11.97M 513M |
| Net Debt | -5.22M -7.37M -6.49M -6.13M -5.56M -10.46M -708M -10.51M -73.45M -28.35M -362M -27.67M -27.08M -1.16B | -6.08M -8.59M -7.56M -7.14M -6.48M -12.18M -824M -12.24M -85.57M -33.02M -421M -32.24M -31.54M -1.35B |
Employees
246
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/09/26 | JOD 3.150 | 0.00% | 2,251 |
| 24/09/26 | JOD 3.150 | 0.00% | 5,020 |
| 23/09/26 | JOD 3.150 | 0.00% | 2,507 |
| 22/09/26 | JOD 3.150 | 0.00% | 6,300 |
- Stock Market
- Stocks
- HPIC Stock
Select your edition
All financial news and data tailored to specific country editions
















